Laryngeal squamous cell carcinoma molecular marker hsa_circ_0018169 as well as detection method and application thereof
A molecular marker, a technology for laryngeal squamous cell carcinoma, which is applied in biochemical equipment and methods, microbial determination/inspection, medical preparations containing active ingredients, etc. It is not strong enough to achieve the effect of inhibiting malignant proliferation, stable results and strong primer specificity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] A detection method and application of the molecular marker hsa_circ_0018169 and its expression in laryngeal squamous cell carcinoma.
[0039] A molecular marker for laryngeal squamous cell carcinoma, the marker is hsa_circ_0018169, the sequence of which is shown in SEQ ID NO:1.
[0040] The laryngeal squamous cell carcinoma molecular marker hsa_circ_0018169 can be applied in the detection and prognosis of laryngeal squamous cell carcinoma.
[0041] The laryngeal squamous cell carcinoma molecular marker hsa_circ_0018169 is used in the preparation of an auxiliary diagnostic kit for laryngeal squamous cell carcinoma.
[0042] A method for detecting molecular expression of laryngeal squamous cell carcinoma molecular marker hsa_circ_0018169 comprises designing real-time fluorescent quantitative primers for hsa_circ_0018169, and obtaining the expression of hsa_circ_0018169 by using a real-time fluorescent quantitative detection method. Including the following steps:
[0043...
Embodiment 2
[0077] The siRNA of hsa_circ_0018169 was synthesized by using the laryngeal cancer molecular marker hsa_circ_0018169 of the present invention.
[0078] First, siRNA for hsa_circ_0018169 was synthesized.
[0079] According to the siRNA design principle, the synthetic sequence contains the circularization site of the circular RNA, and the sequence with a fragment length of 18-25bp is used as the candidate target sequence. In principle, the siRNA with a GC content of about 40%-50% is compared with the database through the database. Human genome sequences were compared to ensure no homology. The designed siRNA sequence of the present invention is as follows:
[0080] Sense strand: 5'-CCUGUAGACAGGUAAAUAC-3'
[0081] Antisense strand: 5'-GUAUUUACCUGUCUACAGG-3'
[0082] Send the above siRNA sequence to Suzhou Gemma Company for chemical synthesis, and add two deoxyribonucleotides dTdT at the 3' end at the same time to increase the stability of siRNA and prevent degradation.
[008...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com